nodes	percent_of_prediction	percent_of_DWPC	metapath
Levonorgestrel—ESR1—ATF-2 transcription factor network—RB1—ocular cancer	0.00387	0.00387	CbGpPWpGaD
Levonorgestrel—ESR1—FOXA1 transcription factor network—CDKN1B—ocular cancer	0.00381	0.00381	CbGpPWpGaD
Levonorgestrel—PGR—Generic Transcription Pathway—TFDP1—ocular cancer	0.00378	0.00378	CbGpPWpGaD
Levonorgestrel—ESR1—FOXM1 transcription factor network—CCND1—ocular cancer	0.00378	0.00378	CbGpPWpGaD
Levonorgestrel—AR—Regulation of Androgen receptor activity—EP300—ocular cancer	0.00375	0.00375	CbGpPWpGaD
Levonorgestrel—AR—Generic Transcription Pathway—E2F5—ocular cancer	0.00372	0.00372	CbGpPWpGaD
Levonorgestrel—PGR—Validated nuclear estrogen receptor alpha network—MYC—ocular cancer	0.00368	0.00368	CbGpPWpGaD
Levonorgestrel—ESR1—Aryl Hydrocarbon Receptor—CDKN1B—ocular cancer	0.00368	0.00368	CbGpPWpGaD
Levonorgestrel—ESR1—Regulation of nuclear SMAD2/3 signaling—CDK2—ocular cancer	0.00366	0.00366	CbGpPWpGaD
Levonorgestrel—AR—Generic Transcription Pathway—E2F4—ocular cancer	0.00365	0.00365	CbGpPWpGaD
Levonorgestrel—AR—Coregulation of Androgen receptor activity—CCND1—ocular cancer	0.00364	0.00364	CbGpPWpGaD
Levonorgestrel—AR—Androgen receptor signaling pathway—RB1—ocular cancer	0.00362	0.00362	CbGpPWpGaD
Levonorgestrel—AR—Generic Transcription Pathway—RBL1—ocular cancer	0.00358	0.00358	CbGpPWpGaD
Levonorgestrel—CYP19A1—Integrated Breast Cancer Pathway—HDAC1—ocular cancer	0.0035	0.0035	CbGpPWpGaD
Levonorgestrel—AR—Nongenotropic Androgen signaling—AKT1—ocular cancer	0.00348	0.00348	CbGpPWpGaD
Levonorgestrel—ESR1—FOXM1 transcription factor network—EP300—ocular cancer	0.00348	0.00348	CbGpPWpGaD
Levonorgestrel—ESR1—Regulation of nuclear SMAD2/3 signaling—CDK4—ocular cancer	0.00346	0.00346	CbGpPWpGaD
Levonorgestrel—ESR1—Estrogen signaling pathway—AKT1—ocular cancer	0.0034	0.0034	CbGpPWpGaD
Levonorgestrel—ESR1—Aryl Hydrocarbon Receptor—CDKN1A—ocular cancer	0.0034	0.0034	CbGpPWpGaD
Levonorgestrel—ESR1—FOXA1 transcription factor network—EP300—ocular cancer	0.00335	0.00335	CbGpPWpGaD
Levonorgestrel—AR—Integrated Breast Cancer Pathway—E2F1—ocular cancer	0.00335	0.00335	CbGpPWpGaD
Levonorgestrel—CYP19A1—FSH signaling pathway—AKT1—ocular cancer	0.00334	0.00334	CbGpPWpGaD
Levonorgestrel—ESR1—Aryl Hydrocarbon Receptor—EP300—ocular cancer	0.00323	0.00323	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Breast Cancer Pathway—HDAC1—ocular cancer	0.00313	0.00313	CbGpPWpGaD
Levonorgestrel—AR—Androgen receptor signaling pathway—MDM2—ocular cancer	0.00309	0.00309	CbGpPWpGaD
Levonorgestrel—AR—Gene Expression—SF3B1—ocular cancer	0.00306	0.00306	CbGpPWpGaD
Levonorgestrel—ESR1—FOXM1 transcription factor network—MYC—ocular cancer	0.00303	0.00303	CbGpPWpGaD
Levonorgestrel—AR—Integrated Pancreatic Cancer Pathway—CDKN2B—ocular cancer	0.00302	0.00302	CbGpPWpGaD
Levonorgestrel—PGR—Generic Transcription Pathway—MAML2—ocular cancer	0.003	0.003	CbGpPWpGaD
Levonorgestrel—ESR1—LKB1 signaling events—MYC—ocular cancer	0.00297	0.00297	CbGpPWpGaD
Levonorgestrel—SRD5A1—Metabolism—GNA11—ocular cancer	0.00296	0.00296	CbGpPWpGaD
Levonorgestrel—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CCND1—ocular cancer	0.00293	0.00293	CbGpPWpGaD
Levonorgestrel—AR—Integrated Breast Cancer Pathway—CDK2—ocular cancer	0.00289	0.00289	CbGpPWpGaD
Levonorgestrel—AR—Generic Transcription Pathway—TFDP1—ocular cancer	0.00288	0.00288	CbGpPWpGaD
Levonorgestrel—CYP19A1—Integrated Breast Cancer Pathway—E2F1—ocular cancer	0.00288	0.00288	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling mediated by p38-alpha and p38-beta—TP53—ocular cancer	0.00288	0.00288	CbGpPWpGaD
Levonorgestrel—ESR1—ATF-2 transcription factor network—CCND1—ocular cancer	0.00288	0.00288	CbGpPWpGaD
Levonorgestrel—ESR1—Generic Transcription Pathway—E2F5—ocular cancer	0.00287	0.00287	CbGpPWpGaD
Levonorgestrel—PGR—Gene Expression—EIF1AX—ocular cancer	0.00283	0.00283	CbGpPWpGaD
Levonorgestrel—ESR1—Aryl Hydrocarbon Receptor—MYC—ocular cancer	0.00282	0.00282	CbGpPWpGaD
Levonorgestrel—ESR1—Generic Transcription Pathway—E2F4—ocular cancer	0.00281	0.00281	CbGpPWpGaD
Levonorgestrel—AR—Regulation of nuclear SMAD2/3 signaling—CDKN1A—ocular cancer	0.0028	0.0028	CbGpPWpGaD
Levonorgestrel—AR—Integrated Pancreatic Cancer Pathway—E2F1—ocular cancer	0.00277	0.00277	CbGpPWpGaD
Levonorgestrel—SRD5A1—Metabolism—GNAQ—ocular cancer	0.00275	0.00275	CbGpPWpGaD
Levonorgestrel—ESR1—Generic Transcription Pathway—RBL1—ocular cancer	0.00275	0.00275	CbGpPWpGaD
Levonorgestrel—AR—Integrated Breast Cancer Pathway—CDK4—ocular cancer	0.00273	0.00273	CbGpPWpGaD
Levonorgestrel—ESR1—Validated nuclear estrogen receptor alpha network—CCND1—ocular cancer	0.0027	0.0027	CbGpPWpGaD
Levonorgestrel—AR—Regulation of nuclear beta catenin signaling and target gene transcription—EP300—ocular cancer	0.0027	0.0027	CbGpPWpGaD
Levonorgestrel—ESR1—Regulation of Telomerase—CDKN1B—ocular cancer	0.00269	0.00269	CbGpPWpGaD
Levonorgestrel—AR—Androgen receptor signaling pathway—CCND1—ocular cancer	0.00269	0.00269	CbGpPWpGaD
Levonorgestrel—AR—Regulation of nuclear SMAD2/3 signaling—EP300—ocular cancer	0.00267	0.00267	CbGpPWpGaD
Levonorgestrel—ESR1—ATF-2 transcription factor network—EP300—ocular cancer	0.00265	0.00265	CbGpPWpGaD
Levonorgestrel—PGR—Signaling by ERBB4—MDM2—ocular cancer	0.00264	0.00264	CbGpPWpGaD
Levonorgestrel—ESR1—AP-1 transcription factor network—CDKN1B—ocular cancer	0.00263	0.00263	CbGpPWpGaD
Levonorgestrel—AR—Androgen receptor signaling pathway—CDKN1A—ocular cancer	0.0026	0.0026	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Breast Cancer Pathway—E2F1—ocular cancer	0.00258	0.00258	CbGpPWpGaD
Levonorgestrel—ESR1—Regulation of Telomerase—CCND1—ocular cancer	0.00257	0.00257	CbGpPWpGaD
Levonorgestrel—ESR1—AP-1 transcription factor network—CCND1—ocular cancer	0.00251	0.00251	CbGpPWpGaD
Levonorgestrel—CYP19A1—Integrated Breast Cancer Pathway—CDK2—ocular cancer	0.00248	0.00248	CbGpPWpGaD
Levonorgestrel—ESR1—Validated nuclear estrogen receptor alpha network—EP300—ocular cancer	0.00248	0.00248	CbGpPWpGaD
Levonorgestrel—AR—Androgen receptor signaling pathway—EP300—ocular cancer	0.00247	0.00247	CbGpPWpGaD
Levonorgestrel—ESR1—LKB1 signaling events—TP53—ocular cancer	0.00244	0.00244	CbGpPWpGaD
Levonorgestrel—ESR1—Plasma membrane estrogen receptor signaling—HRAS—ocular cancer	0.00243	0.00243	CbGpPWpGaD
Levonorgestrel—PGR—Signaling by ERBB4—CDKN1B—ocular cancer	0.00241	0.00241	CbGpPWpGaD
Levonorgestrel—AR—Integrated Pancreatic Cancer Pathway—CDK2—ocular cancer	0.00239	0.00239	CbGpPWpGaD
Levonorgestrel—ESR1—Leptin signaling pathway—CCND1—ocular cancer	0.00237	0.00237	CbGpPWpGaD
Levonorgestrel—AR—Integrated Breast Cancer Pathway—RB1—ocular cancer	0.00237	0.00237	CbGpPWpGaD
Levonorgestrel—ESR1—Gene Expression—SF3B1—ocular cancer	0.00235	0.00235	CbGpPWpGaD
Levonorgestrel—PGR—Gene Expression—E2F5—ocular cancer	0.00235	0.00235	CbGpPWpGaD
Levonorgestrel—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MYC—ocular cancer	0.00235	0.00235	CbGpPWpGaD
Levonorgestrel—CYP19A1—Integrated Breast Cancer Pathway—CDK4—ocular cancer	0.00235	0.00235	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Pancreatic Cancer Pathway—CDKN2B—ocular cancer	0.00233	0.00233	CbGpPWpGaD
Levonorgestrel—AR—Regulation of nuclear SMAD2/3 signaling—MYC—ocular cancer	0.00233	0.00233	CbGpPWpGaD
Levonorgestrel—ESR1—AP-1 transcription factor network—EP300—ocular cancer	0.00231	0.00231	CbGpPWpGaD
Levonorgestrel—PGR—Gene Expression—E2F4—ocular cancer	0.0023	0.0023	CbGpPWpGaD
Levonorgestrel—AR—Generic Transcription Pathway—MAML2—ocular cancer	0.00229	0.00229	CbGpPWpGaD
Levonorgestrel—AR—Integrated Pancreatic Cancer Pathway—CDK4—ocular cancer	0.00226	0.00226	CbGpPWpGaD
Levonorgestrel—PGR—Gene Expression—RPL39—ocular cancer	0.00226	0.00226	CbGpPWpGaD
Levonorgestrel—PGR—Gene Expression—RBL1—ocular cancer	0.00226	0.00226	CbGpPWpGaD
Levonorgestrel—PGR—Signaling by ERBB4—CDKN1A—ocular cancer	0.00222	0.00222	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Breast Cancer Pathway—CDK2—ocular cancer	0.00222	0.00222	CbGpPWpGaD
Levonorgestrel—SRD5A1—Metabolism of lipids and lipoproteins—EP300—ocular cancer	0.00222	0.00222	CbGpPWpGaD
Levonorgestrel—ESR1—Generic Transcription Pathway—TFDP1—ocular cancer	0.00222	0.00222	CbGpPWpGaD
Levonorgestrel—ESR1—Aryl Hydrocarbon Receptor—HRAS—ocular cancer	0.00221	0.00221	CbGpPWpGaD
Levonorgestrel—PGR—Generic Transcription Pathway—HDAC1—ocular cancer	0.0022	0.0022	CbGpPWpGaD
Levonorgestrel—ESR1—Validated nuclear estrogen receptor alpha network—MYC—ocular cancer	0.00216	0.00216	CbGpPWpGaD
Levonorgestrel—ESR1—Regulation of nuclear SMAD2/3 signaling—CDKN1A—ocular cancer	0.00216	0.00216	CbGpPWpGaD
Levonorgestrel—AR—Gene Expression—EIF1AX—ocular cancer	0.00215	0.00215	CbGpPWpGaD
Levonorgestrel—ESR1—Plasma membrane estrogen receptor signaling—AKT1—ocular cancer	0.00214	0.00214	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Pancreatic Cancer Pathway—E2F1—ocular cancer	0.00214	0.00214	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Breast Cancer Pathway—CDK4—ocular cancer	0.0021	0.0021	CbGpPWpGaD
Levonorgestrel—ESR1—Regulation of Telomerase—MYC—ocular cancer	0.00206	0.00206	CbGpPWpGaD
Levonorgestrel—ESR1—Regulation of nuclear SMAD2/3 signaling—EP300—ocular cancer	0.00206	0.00206	CbGpPWpGaD
Levonorgestrel—ESR1—Regulation of Telomerase—TGFB1—ocular cancer	0.00206	0.00206	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—PSPH—ocular cancer	0.00204	0.00204	CbGpPWpGaD
Levonorgestrel—CYP19A1—Integrated Breast Cancer Pathway—RB1—ocular cancer	0.00204	0.00204	CbGpPWpGaD
Levonorgestrel—AR—Coregulation of Androgen receptor activity—AKT1—ocular cancer	0.00202	0.00202	CbGpPWpGaD
Levonorgestrel—AR—Integrated Breast Cancer Pathway—MDM2—ocular cancer	0.00202	0.00202	CbGpPWpGaD
Levonorgestrel—ESR1—AP-1 transcription factor network—MYC—ocular cancer	0.00201	0.00201	CbGpPWpGaD
Levonorgestrel—ESR1—AP-1 transcription factor network—TGFB1—ocular cancer	0.00201	0.00201	CbGpPWpGaD
Levonorgestrel—PGR—Generic Transcription Pathway—CDKN2B—ocular cancer	0.00197	0.00197	CbGpPWpGaD
Levonorgestrel—PGR—Gene Expression—RBBP4—ocular cancer	0.00196	0.00196	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Pancreatic Cancer Pathway—CDK2—ocular cancer	0.00184	0.00184	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Breast Cancer Pathway—RB1—ocular cancer	0.00183	0.00183	CbGpPWpGaD
Levonorgestrel—PGR—Gene Expression—TFDP1—ocular cancer	0.00182	0.00182	CbGpPWpGaD
Levonorgestrel—AR—Gene Expression—E2F5—ocular cancer	0.00179	0.00179	CbGpPWpGaD
Levonorgestrel—ESR1—Regulation of nuclear SMAD2/3 signaling—MYC—ocular cancer	0.00179	0.00179	CbGpPWpGaD
Levonorgestrel—ESR1—Generic Transcription Pathway—MAML2—ocular cancer	0.00176	0.00176	CbGpPWpGaD
Levonorgestrel—AR—Integrated Breast Cancer Pathway—CCND1—ocular cancer	0.00176	0.00176	CbGpPWpGaD
Levonorgestrel—AR—Gene Expression—E2F4—ocular cancer	0.00176	0.00176	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Pancreatic Cancer Pathway—CDK4—ocular cancer	0.00174	0.00174	CbGpPWpGaD
Levonorgestrel—CYP19A1—Integrated Breast Cancer Pathway—MDM2—ocular cancer	0.00174	0.00174	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—SAG—ocular cancer	0.00173	0.00173	CbGpPWpGaD
Levonorgestrel—AR—Gene Expression—RPL39—ocular cancer	0.00172	0.00172	CbGpPWpGaD
Levonorgestrel—AR—Gene Expression—RBL1—ocular cancer	0.00172	0.00172	CbGpPWpGaD
Levonorgestrel—AR—Integrated Pancreatic Cancer Pathway—MDM2—ocular cancer	0.00168	0.00168	CbGpPWpGaD
Levonorgestrel—AR—Generic Transcription Pathway—HDAC1—ocular cancer	0.00167	0.00167	CbGpPWpGaD
Levonorgestrel—ESR1—Gene Expression—EIF1AX—ocular cancer	0.00166	0.00166	CbGpPWpGaD
Levonorgestrel—ESR1—AP-1 transcription factor network—TP53—ocular cancer	0.00165	0.00165	CbGpPWpGaD
Levonorgestrel—AR—Integrated Breast Cancer Pathway—EP300—ocular cancer	0.00162	0.00162	CbGpPWpGaD
Levonorgestrel—AR—Regulation of nuclear SMAD2/3 signaling—AKT1—ocular cancer	0.00161	0.00161	CbGpPWpGaD
Levonorgestrel—AR—SIDS Susceptibility Pathways—EP300—ocular cancer	0.00158	0.00158	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Breast Cancer Pathway—MDM2—ocular cancer	0.00156	0.00156	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling by ERBB4—MDM2—ocular cancer	0.00155	0.00155	CbGpPWpGaD
Levonorgestrel—AR—Integrated Pancreatic Cancer Pathway—CDKN1B—ocular cancer	0.00153	0.00153	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—E2F5—ocular cancer	0.00153	0.00153	CbGpPWpGaD
Levonorgestrel—CYP19A1—Integrated Breast Cancer Pathway—CCND1—ocular cancer	0.00152	0.00152	CbGpPWpGaD
Levonorgestrel—AR—Generic Transcription Pathway—CDKN2B—ocular cancer	0.0015	0.0015	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—E2F4—ocular cancer	0.0015	0.0015	CbGpPWpGaD
Levonorgestrel—ESR1—Leptin signaling pathway—HRAS—ocular cancer	0.0015	0.0015	CbGpPWpGaD
Levonorgestrel—AR—Androgen receptor signaling pathway—AKT1—ocular cancer	0.0015	0.0015	CbGpPWpGaD
Levonorgestrel—AR—Gene Expression—RBBP4—ocular cancer	0.00149	0.00149	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—RBL1—ocular cancer	0.00147	0.00147	CbGpPWpGaD
Levonorgestrel—AR—Integrated Pancreatic Cancer Pathway—CCND1—ocular cancer	0.00146	0.00146	CbGpPWpGaD
Levonorgestrel—PGR—Signaling by ERBB4—HRAS—ocular cancer	0.00145	0.00145	CbGpPWpGaD
Levonorgestrel—PGR—Gene Expression—MAML2—ocular cancer	0.00145	0.00145	CbGpPWpGaD
Levonorgestrel—ESR1—Regulation of Telomerase—AKT1—ocular cancer	0.00143	0.00143	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling by ERBB4—CDKN1B—ocular cancer	0.00141	0.00141	CbGpPWpGaD
Levonorgestrel—AR—Integrated Breast Cancer Pathway—MYC—ocular cancer	0.00141	0.00141	CbGpPWpGaD
Levonorgestrel—AR—Integrated Pancreatic Cancer Pathway—CDKN1A—ocular cancer	0.00141	0.00141	CbGpPWpGaD
Levonorgestrel—CYP19A1—Integrated Breast Cancer Pathway—EP300—ocular cancer	0.0014	0.0014	CbGpPWpGaD
Levonorgestrel—AR—Gene Expression—TFDP1—ocular cancer	0.00139	0.00139	CbGpPWpGaD
Levonorgestrel—ESR1—Gene Expression—E2F5—ocular cancer	0.00138	0.00138	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Breast Cancer Pathway—CCND1—ocular cancer	0.00136	0.00136	CbGpPWpGaD
Levonorgestrel—ESR1—Gene Expression—E2F4—ocular cancer	0.00135	0.00135	CbGpPWpGaD
Levonorgestrel—AR—Integrated Pancreatic Cancer Pathway—EP300—ocular cancer	0.00134	0.00134	CbGpPWpGaD
Levonorgestrel—ESR1—Gene Expression—RPL39—ocular cancer	0.00133	0.00133	CbGpPWpGaD
Levonorgestrel—ESR1—Gene Expression—RBL1—ocular cancer	0.00133	0.00133	CbGpPWpGaD
Levonorgestrel—ESR1—Leptin signaling pathway—AKT1—ocular cancer	0.00132	0.00132	CbGpPWpGaD
Levonorgestrel—CYP3A4—Tryptophan metabolism—MDM2—ocular cancer	0.00131	0.00131	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling by ERBB4—CDKN1A—ocular cancer	0.00131	0.00131	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Pancreatic Cancer Pathway—MDM2—ocular cancer	0.00129	0.00129	CbGpPWpGaD
Levonorgestrel—ESR1—Generic Transcription Pathway—HDAC1—ocular cancer	0.00129	0.00129	CbGpPWpGaD
Levonorgestrel—PGR—Signaling by ERBB4—AKT1—ocular cancer	0.00128	0.00128	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—E2F3—ocular cancer	0.00127	0.00127	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Breast Cancer Pathway—EP300—ocular cancer	0.00125	0.00125	CbGpPWpGaD
Levonorgestrel—ESR1—Regulation of nuclear SMAD2/3 signaling—AKT1—ocular cancer	0.00124	0.00124	CbGpPWpGaD
Levonorgestrel—CYP19A1—Integrated Breast Cancer Pathway—MYC—ocular cancer	0.00122	0.00122	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—TFDP1—ocular cancer	0.00118	0.00118	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Pancreatic Cancer Pathway—CDKN1B—ocular cancer	0.00118	0.00118	CbGpPWpGaD
Levonorgestrel—AR—Integrated Pancreatic Cancer Pathway—MYC—ocular cancer	0.00117	0.00117	CbGpPWpGaD
Levonorgestrel—AR—Integrated Pancreatic Cancer Pathway—TGFB1—ocular cancer	0.00117	0.00117	CbGpPWpGaD
Levonorgestrel—AR—Integrated Breast Cancer Pathway—TP53—ocular cancer	0.00116	0.00116	CbGpPWpGaD
Levonorgestrel—ESR1—Generic Transcription Pathway—CDKN2B—ocular cancer	0.00116	0.00116	CbGpPWpGaD
Levonorgestrel—ESR1—Gene Expression—RBBP4—ocular cancer	0.00115	0.00115	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Pancreatic Cancer Pathway—CCND1—ocular cancer	0.00112	0.00112	CbGpPWpGaD
Levonorgestrel—AR—Gene Expression—MAML2—ocular cancer	0.0011	0.0011	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Breast Cancer Pathway—MYC—ocular cancer	0.00109	0.00109	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Pancreatic Cancer Pathway—CDKN1A—ocular cancer	0.00109	0.00109	CbGpPWpGaD
Levonorgestrel—ESR1—Gene Expression—TFDP1—ocular cancer	0.00107	0.00107	CbGpPWpGaD
Levonorgestrel—PGR—Gene Expression—HDAC1—ocular cancer	0.00106	0.00106	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Pancreatic Cancer Pathway—EP300—ocular cancer	0.00103	0.00103	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—SAG—ocular cancer	0.00101	0.00101	CbGpPWpGaD
Levonorgestrel—CYP19A1—Integrated Breast Cancer Pathway—TP53—ocular cancer	0.000998	0.000998	CbGpPWpGaD
Levonorgestrel—SRD5A1—Metabolism—EP300—ocular cancer	0.00099	0.00099	CbGpPWpGaD
Levonorgestrel—AR—Integrated Breast Cancer Pathway—AKT1—ocular cancer	0.00098	0.00098	CbGpPWpGaD
Levonorgestrel—AR—Integrated Pancreatic Cancer Pathway—TP53—ocular cancer	0.000961	0.000961	CbGpPWpGaD
Levonorgestrel—PGR—Gene Expression—CDKN2B—ocular cancer	0.000948	0.000948	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—MAML2—ocular cancer	0.000941	0.000941	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Pancreatic Cancer Pathway—MYC—ocular cancer	0.000902	0.000902	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Pancreatic Cancer Pathway—TGFB1—ocular cancer	0.0009	0.0009	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—E2F5—ocular cancer	0.000897	0.000897	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Breast Cancer Pathway—TP53—ocular cancer	0.000894	0.000894	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—E2F4—ocular cancer	0.000879	0.000879	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—RBL1—ocular cancer	0.000862	0.000862	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling by ERBB4—HRAS—ocular cancer	0.00085	0.00085	CbGpPWpGaD
Levonorgestrel—ESR1—Gene Expression—MAML2—ocular cancer	0.000849	0.000849	CbGpPWpGaD
Levonorgestrel—CYP19A1—Integrated Breast Cancer Pathway—AKT1—ocular cancer	0.000843	0.000843	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—GNA11—ocular cancer	0.000821	0.000821	CbGpPWpGaD
Levonorgestrel—AR—Integrated Pancreatic Cancer Pathway—AKT1—ocular cancer	0.000812	0.000812	CbGpPWpGaD
Levonorgestrel—AR—Gene Expression—HDAC1—ocular cancer	0.000806	0.000806	CbGpPWpGaD
Levonorgestrel—PGR—Generic Transcription Pathway—MYC—ocular cancer	0.000763	0.000763	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—GNAQ—ocular cancer	0.000763	0.000763	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Breast Cancer Pathway—AKT1—ocular cancer	0.000755	0.000755	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling by ERBB4—AKT1—ocular cancer	0.000751	0.000751	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—E2F3—ocular cancer	0.000747	0.000747	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Pancreatic Cancer Pathway—TP53—ocular cancer	0.000741	0.000741	CbGpPWpGaD
Levonorgestrel—AR—Gene Expression—CDKN2B—ocular cancer	0.000722	0.000722	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—TFDP1—ocular cancer	0.000695	0.000695	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—HDAC1—ocular cancer	0.000688	0.000688	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—GNA11—ocular cancer	0.000643	0.000643	CbGpPWpGaD
Levonorgestrel—ESR1—Integrated Pancreatic Cancer Pathway—AKT1—ocular cancer	0.000625	0.000625	CbGpPWpGaD
Levonorgestrel—ESR1—Gene Expression—HDAC1—ocular cancer	0.000621	0.000621	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—CDKN2B—ocular cancer	0.000617	0.000617	CbGpPWpGaD
Levonorgestrel—SRD5A1—Metabolism—AKT1—ocular cancer	0.000598	0.000598	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—GNAQ—ocular cancer	0.000598	0.000598	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—PSPH—ocular cancer	0.000597	0.000597	CbGpPWpGaD
Levonorgestrel—AR—Generic Transcription Pathway—MYC—ocular cancer	0.000582	0.000582	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—E2F1—ocular cancer	0.000566	0.000566	CbGpPWpGaD
Levonorgestrel—ESR1—Gene Expression—CDKN2B—ocular cancer	0.000557	0.000557	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—MAML2—ocular cancer	0.000552	0.000552	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism of lipids and lipoproteins—EP300—ocular cancer	0.000483	0.000483	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—GNA11—ocular cancer	0.000482	0.000482	CbGpPWpGaD
Levonorgestrel—ESR1—Generic Transcription Pathway—MYC—ocular cancer	0.000448	0.000448	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—GNAQ—ocular cancer	0.000448	0.000448	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—HDAC1—ocular cancer	0.000404	0.000404	CbGpPWpGaD
Levonorgestrel—PGR—Gene Expression—MYC—ocular cancer	0.000367	0.000367	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—CDKN2B—ocular cancer	0.000362	0.000362	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—MDM2—ocular cancer	0.000342	0.000342	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—E2F1—ocular cancer	0.000332	0.000332	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—CDKN1B—ocular cancer	0.000312	0.000312	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—CCND1—ocular cancer	0.000298	0.000298	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—CDKN1A—ocular cancer	0.000288	0.000288	CbGpPWpGaD
Levonorgestrel—AR—Gene Expression—MYC—ocular cancer	0.00028	0.00028	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—EP300—ocular cancer	0.000274	0.000274	CbGpPWpGaD
Levonorgestrel—PGR—Gene Expression—AKT1—ocular cancer	0.000255	0.000255	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—MYC—ocular cancer	0.000239	0.000239	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—TGFB1—ocular cancer	0.000238	0.000238	CbGpPWpGaD
Levonorgestrel—ESR1—Gene Expression—MYC—ocular cancer	0.000216	0.000216	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—EP300—ocular cancer	0.000215	0.000215	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—MDM2—ocular cancer	0.000201	0.000201	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—TP53—ocular cancer	0.000196	0.000196	CbGpPWpGaD
Levonorgestrel—AR—Gene Expression—AKT1—ocular cancer	0.000194	0.000194	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—GNA11—ocular cancer	0.000188	0.000188	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—HRAS—ocular cancer	0.000188	0.000188	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—CDKN1B—ocular cancer	0.000183	0.000183	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—CCND1—ocular cancer	0.000175	0.000175	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—GNAQ—ocular cancer	0.000175	0.000175	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—CDKN1A—ocular cancer	0.000169	0.000169	CbGpPWpGaD
Levonorgestrel—PGR—Signaling Pathways—AKT1—ocular cancer	0.000166	0.000166	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—EP300—ocular cancer	0.000161	0.000161	CbGpPWpGaD
Levonorgestrel—ESR1—Gene Expression—AKT1—ocular cancer	0.00015	0.00015	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—MYC—ocular cancer	0.00014	0.00014	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—TGFB1—ocular cancer	0.00014	0.00014	CbGpPWpGaD
Levonorgestrel—CYP19A1—Metabolism—AKT1—ocular cancer	0.00013	0.00013	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—TP53—ocular cancer	0.000115	0.000115	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—HRAS—ocular cancer	0.00011	0.00011	CbGpPWpGaD
Levonorgestrel—ESR1—Signaling Pathways—AKT1—ocular cancer	9.72e-05	9.72e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—EP300—ocular cancer	6.27e-05	6.27e-05	CbGpPWpGaD
Levonorgestrel—CYP3A4—Metabolism—AKT1—ocular cancer	3.79e-05	3.79e-05	CbGpPWpGaD
